L. de Haan

1.1k total citations
20 papers, 403 citations indexed

About

L. de Haan is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, L. de Haan has authored 20 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 5 papers in Cognitive Neuroscience. Recurrent topics in L. de Haan's work include Schizophrenia research and treatment (6 papers), Mental Health and Psychiatry (4 papers) and Bipolar Disorder and Treatment (3 papers). L. de Haan is often cited by papers focused on Schizophrenia research and treatment (6 papers), Mental Health and Psychiatry (4 papers) and Bipolar Disorder and Treatment (3 papers). L. de Haan collaborates with scholars based in Netherlands, United Kingdom and Australia. L. de Haan's co-authors include Henriëtte D. Heering, Herman N. Sno, D.H. Linszen, Peter Dingemans, Dorien H. Nieman, Eva Velthorst, Hiske E. Becker, M. Weiser, Stephan Ruhrmann and Lo J. Bour and has published in prestigious journals such as The British Journal of Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

L. de Haan

20 papers receiving 398 citations

Peers

Countries citing papers authored by L. de Haan

Since Specialization

Citations

This map shows the geographic impact of L. de Haan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. de Haan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. de Haan more than expected).

Fields of papers citing papers by L. de Haan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. de Haan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. de Haan. The network helps show where L. de Haan may publish in the future.

Co-authorship network of co-authors of L. de Haan

This figure shows the co-authorship network connecting the top 25 collaborators of L. de Haan. A scholar is included among the top collaborators of L. de Haan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. de Haan. L. de Haan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study 2021 ·Epidemiology and Psychiatric Sciences ·Isabell Paetzold, Inez Myin‐Germeys, Anita Schick, Barnaby Nelson, Eva Velthorst, Frederike Schirmbeck, (unknown), Jim van Os, Craig Morgan, Jessica Hartmann, Mark van der Gaag, L. de Haan, Lucia Valmaggia, Philip McGuire, Matthew J. Kempton, Ulrich Reininghaus	19
2	Low prevalence of substance use in people with 22q11.2 deletion syndrome 2019 ·The British Journal of Psychiatry ·Claudia Vingerhoets, (unknown), Oswald Bloemen, Erik Boot, (unknown), L. J. M. Evers, Ania Fiksinski, Elemi Breetvelt, (unknown), Elfi Vergaelen, Annick Vogels, Carin J. Meijer, Jan Booij, (unknown), L. de Haan, Ann Swillen, Jacob Vorstman, Anne S. Bassett, Thérèse van Amelsvoort	12
3	Antipsychotic medication and long-term mortality risk in patients with schizophrenia 2017 ·Jentien M. Vermeulen, (unknown), (unknown), (unknown), Mirjam van Tricht, L. de Haan	24
4	Longitudinal study of hippocampal volumes in heavy cannabis users 2017 ·Journal of Psychopharmacology ·Laura Koenders, Valentina Lorenzetti, L. de Haan, Chao Suo, (unknown), Wim van den Brink, Reínout W. Wiers, C. J. Meijer, (unknown), (unknown), (unknown), Murat Yücel, Janna Cousijn	34
5	Cannabis and a lower BMI in psychosis: What is the role of AKT1? 2016 ·Schizophrenia Research ·Edith J. Liemburg, Jojanneke Bruins, Nico van Beveren, Md. Atiqul Islam, Behrooz Z. Alizadeh, Richard Bruggeman, D. Wiersma, Wiepke Cahn, R.S. Kahn, L. de Haan, C. J. Meijer, Inez Myin‐Germeys, Jim van Os	10
6	THE NEURAPRO-E STUDY: A MULTICENTER RCT OF OMEGA-3 FATTY ACIDS AND COGNITIVE-BEHAVIOURAL CASE MANAGEMENT FOR PATIENTS AT ULTRA HIGH RISK OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS 2015 ·Schizophrenia Bulletin ·Patrick D. McGorry, Connie Markulev, Barnaby Nelson, (unknown), Miriam Schaefer, Alison R. Yung, Andrew Thompson, (unknown), Nilufar Mossaheb, Monika Schloegelhofer, Stefan Smesny, L. de Haan, Anita Riecher‐Rössler, Merete Nordentoft, Eric Chen, Swapna Verma, Ian B. Hickie, G. Paul Amminger	1
7	Long-term Outcome in Schizophrenia: a Six-year Follow-up in over 1000 Patients 2015 ·European Psychiatry ·Wiepke Cahn, Richard Bruggeman, L. de Haan, René S. Kahn, Inez Myin‐Germeys, Jim van Os	1
8	Psychosis Prediction: Stratification of Risk Estimation With Information-Processing and Premorbid Functioning Variables 2013 ·Schizophrenia Bulletin ·Dorien H. Nieman, Stephan Ruhrmann, Sara Dragt, (unknown), Mirjam J. van Tricht, J.H.T.M. Koelman, Lo J. Bour, Eva Velthorst, Hiske E. Becker, M. Weiser, D.H. Linszen, L. de Haan	68
9	Schizophrenia as a self-disorder due to perceptual incoherence 2013 ·Schizophrenia Research ·(unknown), Herman N. Sno, (unknown), (unknown), Henriëtte D. Heering, L. de Haan	142
10	Treating prolactinoma and psychosis: medication and cognitive behavioural therapy 2011 ·BMJ Case Reports ·Dorien H. Nieman, Arjen L. Sutterland, (unknown), Hiske E. Becker, Marjolein Drent, Mark van der Gaag, Max Birchwood, L. de Haan	2
11	Routine outcome monitoring voor patiënten met ernstige psychiatrische aandoeningen; een consensusdocument 2010 ·Data Archiving and Networked Services (DANS) ·C.L. Mulder, Mark van der Gaag, Richard Bruggeman, Wiepke Cahn, Philippe Delespaul, (unknown), (unknown), L. de Haan, F.M.M.A. van der Heijden, (unknown), (unknown), C. J. Slooff, Sjoerd Sytema, D. Wiersma, Lex Wunderink, Jim van Os	6
12	White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med 2009 ·Oswald Bloemen, Mariken B. de Koning, (unknown), Dorien H. Nieman, Hiske E. Becker, L. de Haan, Peter Dingemans, D.H. Linszen, Thérèse van Amelsvoort	10
13	EFFECT OF BDNF VAL66MET POLYMORPHISM ON BRAIN ANATOMY IN FIRST EPISODE SCHIZOPHRENIA 2008 ·Schizophrenia Research ·(unknown), Nicole Schmitz, Janneke Zinkstok, L. de Haan, Frank Baas, D.H. Linszen	1
14	Risk Factors for Medication Non-Adherence in Patients with First Episode Schizophrenia and Related Disorders; A Prospective Five Year Follow-Up 2007 ·Pharmacopsychiatry ·L. de Haan, (unknown), Peter Dingemans, D.H. Linszen	41
15	0251 FAMILY MOTIVATIONAL INTERVENTION: TRAINING MOTIVATIONAL INTERVIEWING FOR FAMILY MEMBERS OF PATIENTS WITH SCHIZOPHRENIA, CANNABIS USE AND POOR COMPLIANCE 2006 ·Schizophrenia Research ·Ireneus P.M. Keet, (unknown), L. de Haan, Gerard M. Schippers, D.H. Linszen	3
16	FC10D THE AMSTERDAM CRITICAL PERIOD INTERVENTION IN THE EARLY PHASE OF SCHIZOPHRENIA-LIKE PSYCHOSES 2006 ·Schizophrenia Research ·D.H. Linszen, L. de Haan, Peter Dingemans, (unknown), Thérèse van Amelsvoort, L. Wouters	5
17	Treatment reluctance in first episode schizophrenia: Lack of insight, non-compliance and cannabis abuse predict bad outcome after eighteen months intervention 2003 ·Schizophrenia Research ·D.H. Linszen, L. de Haan, Peter Dingemans, (unknown), (unknown), (unknown), (unknown)	7
18	Patients' perspectives. Subjective experiences and attitudes of patients with recent onset schizophrenia 2002 ·UvA-DARE (University of Amsterdam) ·L. de Haan	2
19	[Schizophrenia and the 22q11 deletion syndrome]. 2002 ·PubMed ·Yener Güzelcan, (unknown), L. de Haan, (unknown), Don Linszen	1
20	Preferences for treatment during a first psychotic episode 2001 ·European Psychiatry ·L. de Haan, (unknown), Richard J. B. H. N. van den Berg, Markus Jäger, (unknown), (unknown), (unknown), D.H. Linszen, Bart D. Peters, L. Wouters	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact